Esomeprazole (brand names Sompraz, Zoleri, Nexium, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium and South Africa)

By admin - Last updated: Tuesday, March 9, 2010

Esomeprazole (brand names Sompraz, Zoleri, Nexium, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium and South Africa)

You can buy Esomeprazole online without prescription in this online medical markets

Esomeprazole

40 mg Nexium brand esomeprazole capsules

Esomeprazole is a proton pump inhibitor (brand names Sompraz, Zoleri, Nexium, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium and South Africa) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole (marketed as Losec/Prilosec), and AstraZeneca claims improved efficacy of this single enantiomer product over the racemic mixture of omeprazole. However, this greater efficacy has been disputed, with some[who?] claiming it offers no benefit from its older form.

Read the rest of this entry »


Read more...

Filed in Esomeprazole

The Vitamin D Cure Blog » Blog Archive » Celebrate the Winter

By jdowd - Last updated: Wednesday, December 23, 2009

1,25-dihydroxycholecalciferol activates CYP3A4, an enzyme of the cytochrome P450 system, which metabolizes atorvastatin to its main metabolites. The objective of this study was to evaluate the response of cholesterol and triglycerides …


Read more...

Filed in Atorvastatin

Can anyone name the members of the Five Statins? | Alternative

By admin - Last updated: Wednesday, December 23, 2009

Simvastatin Zocor, Lipex Fermentation-derived. (Simvastatin is a synthetic derivate of a fermentation product) Simvastatin+Ezetimibe Vytorin Combination therapy. Lovastatin+Niacin extended-release Advicor Combination therapy …


Read more...

Filed in Simvastatin

Ezetimibe and cancer risk

By unknown - Last updated: Tuesday, December 22, 2009

The review is a follow-up to the August 2008 “early communication” about the safety of ezetimibe and simvastatin that was spurred by data from the SEAS trial. The interim review was reported by heartwire, as was an independent cancer …


Read more...

Filed in Simvastatin

FDA Finds It Unlikely Than Vytorin Or Zetia Increases Risk Of

By Tom Lamb - Last updated: Tuesday, December 22, 2009

December 2009 Update From FDA For Its August 2008 Early Communication About Safety Review of Ezetimibe / Simvastatin (Vytorin) And Ezetimibe (Zetia) (Posted by Tom Lamb at DrugInjuryWatch.com) On December 22, 2009 the FDA issued an …


Read more...

Filed in Simvastatin